Citation
Zhou, Yingjie, et al. "Liquid Chromatography/tandem Mass Spectrometry Assay for the Simultaneous Determination of Cefoperazone and Sulbactam in Plasma and Its Application to a Pharmacokinetic Study." Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, vol. 878, no. 30, 2010, pp. 3119-24.
Zhou Y, Zhang J, Guo B, et al. Liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of cefoperazone and sulbactam in plasma and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(30):3119-24.
Zhou, Y., Zhang, J., Guo, B., Yu, J., Shi, Y., Wang, M., & Zhang, Y. (2010). Liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of cefoperazone and sulbactam in plasma and its application to a pharmacokinetic study. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 878(30), 3119-24. https://doi.org/10.1016/j.jchromb.2010.09.021
Zhou Y, et al. Liquid Chromatography/tandem Mass Spectrometry Assay for the Simultaneous Determination of Cefoperazone and Sulbactam in Plasma and Its Application to a Pharmacokinetic Study. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 15;878(30):3119-24. PubMed PMID: 20971044.
TY - JOUR
T1 - Liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of cefoperazone and sulbactam in plasma and its application to a pharmacokinetic study.
AU - Zhou,Yingjie,
AU - Zhang,Jing,
AU - Guo,Beining,
AU - Yu,Jicheng,
AU - Shi,Yaoguo,
AU - Wang,Minggui,
AU - Zhang,Yingyuan,
Y1 - 2010/10/01/
PY - 2010/03/06/received
PY - 2010/08/30/revised
PY - 2010/09/22/accepted
PY - 2010/10/26/entrez
PY - 2010/10/26/pubmed
PY - 2011/1/29/medline
SP - 3119
EP - 24
JF - Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
JO - J Chromatogr B Analyt Technol Biomed Life Sci
VL - 878
IS - 30
N2 - A rapid and highly sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method for simultaneous determination of cefoperazone sodium and sulbactam sodium in human plasma was developed. The analytes and internal standard (IS), cefuroxime sodium, were extracted from human plasma via liquid-liquid extraction with ethyl acetate and separated on a Waters Xterra C18 column within 3.5 min. Quantitation was performed on a triple quadrupole mass spectrometer employing electrospray ionization technique, operating in selected reaction monitoring (SRM) and negative ion mode. The precursor to product ion transitions monitored for cefoperazone, sulbactam and IS were m/z 644.1→528.0, 232.1→140.0, and 423.0→362.0, respectively. The assay was validated in the linear range of 0.1-20 μg/mL for cefoperazone and 0.02-4 μg/mL for sulbactam. The intra- and inter-day precisions (CV%) were within 8.39% for each analyte. The recoveries were greater than 87.3% for cefoperazone and 87.2% for sulbactam. Each analyte was found to be stable during all sample storage, preparation and analytical procedures. The method was successfully applied in a pharmacokinetic study of Sulperazon injection in six hospital-acquired pneumonia (HAP) patients.
SN - 1873-376X
UR - https://www.unboundmedicine.com/medline/citation/20971044/Liquid_chromatography/tandem_mass_spectrometry_assay_for_the_simultaneous_determination_of_cefoperazone_and_sulbactam_in_plasma_and_its_application_to_a_pharmacokinetic_study_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S1570-0232(10)00608-2
DB - PRIME
DP - Unbound Medicine
ER -